MY148088A - Stable nanoparticle formulations - Google Patents

Stable nanoparticle formulations

Info

Publication number
MY148088A
MY148088A MYPI20071748A MY148088A MY 148088 A MY148088 A MY 148088A MY PI20071748 A MYPI20071748 A MY PI20071748A MY 148088 A MY148088 A MY 148088A
Authority
MY
Malaysia
Prior art keywords
nanoparticle formulations
stable nanoparticle
formulations
stable
processes
Prior art date
Application number
Inventor
Abu-Izza Khawla Abdullah
Original Assignee
Sanofi Aventis Us Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Us Llc filed Critical Sanofi Aventis Us Llc
Priority to MYPI20071748 priority Critical patent/MY148088A/en
Publication of MY148088A publication Critical patent/MY148088A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

THE INVENTION RELATES TO PHARMACEUTICALLY STABLE NANOPARTICLE FORMULATIONS OF POORLY SOLUBLE DRUG SUBSTANCES, TO THE PROCESSES FOR THE PREPARATION OF SUCH FORMULATIONS, AND TO METHODS OF USE THEREOF.
MYPI20071748 2007-10-10 2007-10-10 Stable nanoparticle formulations MY148088A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20071748 MY148088A (en) 2007-10-10 2007-10-10 Stable nanoparticle formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20071748 MY148088A (en) 2007-10-10 2007-10-10 Stable nanoparticle formulations

Publications (1)

Publication Number Publication Date
MY148088A true MY148088A (en) 2013-02-28

Family

ID=50280712

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20071748 MY148088A (en) 2007-10-10 2007-10-10 Stable nanoparticle formulations

Country Status (1)

Country Link
MY (1) MY148088A (en)

Similar Documents

Publication Publication Date Title
MX354210B (en) Controlled release oral dosage forms of poorly soluble drugs and uses thereof.
WO2009121039A3 (en) Administration of benzodiazepine compositions
EP3626253A3 (en) Stable formulations of linaclotide
IL208832A (en) 3-aminocarbazole compounds, pharmaceutical compositions containing them, preparation methods thereof and use thereof in the production of drugs
EP4327888A3 (en) Oral formulations of cytidine analogs and methods of use thereof
WO2009012303A3 (en) Therapeutic stable nanoparticles
WO2010021607A3 (en) Pharmaceutical formulation
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
MY156288A (en) Pharmaceutical formulations containing dopamine receptor ligands.
PH12013502192A1 (en) Antibodies against human angiopoietin 2
WO2008066899A3 (en) Nanoparticulate formulations and methods for the making and use thereof
TW200716646A (en) (S)-N-methylnaltrexone
WO2012174158A3 (en) Administration of benzodiazepine
WO2009153346A3 (en) Stabilization of amorphous drugs using sponge-like carrier matrices
TNSN08284A1 (en) Masking the taste of powders
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
WO2011002422A3 (en) Solubility enhancing pharmaceutical formulation
EP2196463A4 (en) Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
NO20076120L (en) Stable nanoparticle formulations
WO2009048940A3 (en) Diacerein pharmaceutical formulations
WO2009084036A3 (en) Composition for treatment of viral infections
IL191922A0 (en) Pharmaceutical formulations of oxcarbazepine and methods for its preparation
WO2007114946A3 (en) Acid-sensitive linkers for drug delivery
WO2011133894A3 (en) Protein drug formulations and packages